Skip to main content
LGVN logo

Longeveron Inc. (LGVN)

LGVNNASDAQHealthcareBiotechnology

$1.66Today:−$0.09 (−5.21%)1Y +203.33%

As of Nov 20, 2026 close

Market cap
$5.84M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.48$8.90
Volume (live)
-
Avg. volume (3M)
90.25K

Longeveron (LGVN) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Longeveron used $18.64M of cash in operating activities and spent $245.00K on capital expenditures. That left free cash flow of −$18.89M. It repurchased $311.00K of its own shares.

Longeveron Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Longeveron Inc. (LGVN) - Annual data in millions USD
BreakdownTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingSep 2026Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-22.39-22.70-15.97-21.41-18.84-17.05-3.72-2.96-6.34
Depreciation & Amortization0.981.230.960.950.890.910.790.770.75
Stock Based Compensation1.651.682.332.032.177.740.080.140.42
Change in Working Capital1.661.06-1.24-1.080.24-1.090.49-0.22-0.01
Change in Accounts Receivable-0.01-0.020.030.11-0.160.370.03-0.450.02
Change in Inventory-0.000.000.000.00-0.37-0.030.000.00
Change in Accounts Payable0.880.33-0.54-1.111.11-0.950.130.00-0.01
Change in Other Working Capital-0.260.75-0.72-0.07-0.70-0.150.860.230.00
Other Operating Activities-0.100.060.221.57-0.160.00-0.121.90
Net Cash from Operating Activities-18.01-18.65-13.87-19.00-13.97-9.64-2.36-2.39-5.18
Investing Activities
Capital Expenditures-0.19-0.25-0.99-0.30-0.86-1.31-0.13-0.04-0.21
Acquisitions-0.000.000.000.000.090.000.000.00
Purchases of Investments-0.000.358.880.00-9.470.000.000.00
Sales/Maturities of Investments-0.000.358.880.189.39-0.130.000.00
Other Investing Activities-0.000.008.490.00-9.390.00-0.09-0.12
Net Cash from Investing Activities-0.25-0.60-0.648.19-0.68-10.70-0.26-0.13-0.21
Financing Activities
Debt Repayment-0.000.000.000.00-0.19-0.030.000.00
Common Stock Issued-4.9812.875.440.0045.191.150.001.36
Common Stock Repurchased-0.14-0.31-0.37-0.170.000.000.000.000.00
Dividends Paid-0.00-8.650.000.000.000.000.000.00
Other Financing Activities0.60-0.31-0.275.44-0.51-0.45-0.060.351.36
Net Cash from Financing Activities16.264.6728.795.26-0.5145.171.580.351.36
Summary
Net Change in Cash-2.00-14.5714.28-5.55-15.1624.84-1.05-2.17-4.04
Cash at Beginning of Period9.2419.234.9510.5025.660.821.874.038.07
Cash at End of Period7.254.6619.234.9510.5025.660.821.874.03
Free Cash Flow-18.18-18.89-14.86-19.30-14.83-10.95-2.50-2.43-5.39

Source: Company financial statements from annual and quarterly filings. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions About Longeveron Cash Flow

What is Longeveron's free cash flow?

Longeveron had negative free cash flow of $18.89M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$18.64M minus $245.00K of capital expenditures.

How much does Longeveron spend on capital expenditures?

Longeveron spent $245.00K on capital expenditures in fiscal 2025, compared with $992.00K a year earlier.

Does Longeveron pay dividends or buy back shares?

Yes. In fiscal 2025 Longeveron returned $311.00K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition